REGISTERED NUMBER: 16511758 (England and Wales)

FINANCIAL STATEMENTS FOR THE PERIOD 11 JUNE 2025 TO 31 DECEMBER 2025

FOR

ANYWELL HEALTH UK LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

R Kokken

REGISTERED OFFICE:

7 St John's Road

Harrow

Middlesex

HA1 2EY

REGISTERED NUMBER:

16511758 (England and Wales)

AUDITORS:

MCA Audit Limited

7 St John's Road

Harrow

HA1 2EY

FIXED ASSETS

Intangible assets

4

12,500

CURRENT ASSETS

Debtors

5

966

Cash at bank

6,536

7,502

CREDITORS

Amounts falling due within one year

6

24,019

NET CURRENT LIABILITIES

(16,517

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(4,017

)

CAPITAL AND RESERVES

Called up share capital

100

Retained earnings

(4,117

)

(4,017

)

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 August 2026 and were signed by:

R Kokken - Director

1.	STATUTORY INFORMATION

Anywell Health UK Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities"and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern

The financial statements have been prepared on a going concern basis, notwithstanding the company's net current liabilities position as at the period end. The company's ultimate parent company has confirmed its intention to continue providing financial support to the company for the foreseeable future. It has also undertaken not to demand repayment of the amounts currently owing to it for a period of at least twelve months from the date of approval of these financial statements.

Related party exemption

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and impairment losses.

The capitalised licence cost was not brought into use during the reporting period; therefore, no amortisation has been recognised in the current period.

Financial instruments

Financial assets and liabilities are recognized in the company's balance sheet when the company becomes a party to the contractual provisions of the instrument.

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4.	INTANGIBLE FIXED ASSETS

Software

and

licenses

£

COST

Additions

12,500

At 31 December 2025

12,500

NET BOOK VALUE

At 31 December 2025

12,500

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Other debtors

966

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Trade creditors

998

Amounts owed to group undertakings

20,500

Other creditors

2,521

24,019

7.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Shailesh Patel (Senior Statutory Auditor)

for and on behalf of MCA Audit Limited

8.	ULTIMATE PARENT AND CONTROLLING PARTY

The company is a wholly owned subsidiary of Anywell Health Holding B.V., a company registered in Netherlands. The director considers Anywell Health Holding B.V. to be the ultimate controlling party.